炎症性肠病的基准测试:澳大利亚和新西兰的经验教训
Peter Litwin1, Jane Andrews1,2
1Department of Gastroenterology, Royal Adelaide Hospital, Adelaide, SA 5000, Australia.
Journal of the Canadian Association of Gastroenterology
|February 24, 2025
概括
在炎症性肠病 (IBD) 护理中,质量评估和基准测试至关重要,但资源密集. 澳大利亚和新西兰的一种基于云的新型电子医疗记录 (EMR) 系统,CCCare,自动收集数据以进行有效的IBD基准测试.
科学领域:
- 胃肠病学和临床质量改善
- 卫生信息学和数据管理数据管理
背景情况:
- 炎症性肠病 (IBD) 影响近1%的西方人口,需要积极的护理模式.
- 目前的IBD护理缺乏有效的反循环,原因是对质量和结果的理解不足.
- 医疗保健中的质量评估包括评估结构,过程和结果.
研究的目的:
- 讨论 IBD 管理中的护理质量,指导方针和标准的重要性.
- 在IBD中引入一种用于自动化质量评估和基准分析的新型解决方案.
- 介绍基于云的IBD电子医疗记录 (EMR) 系统的开发和实施.
主要方法:
- 讨论质量评估的核心领域:结构,过程和结果.
- 解释基准测试作为一种方法,以进行护理场所之间的透明质量比较.
- 在澳大利亚和新西兰的22个地点实施基于云的,针对IBD的EMR (Crohn's Colitis Care - CCCare).
- 利用CCCare的非身份化数据,将其输入临床质量注册表,用于审计,研究和基准测试.
主要成果:
- CCCare是一个新的,基于云的EMR,为IBD患者提供常规护理文件.
- 该系统可实现自动数据收集,使质量评估和基准测试更加负担得起和可持续.
- 来自CCCare的非识别数据支持临床质量注册表,用于全面分析IBD数据.
结论:
- 通过像CCCare这样的数字工具进行自动数据收集,为IBD质量评估和基准测试提供了一个可持续的解决方案.
- 从ANZ基准评估计划中吸取的经验教训可以为IBD数据利用的全球方法提供信息.
- 解决隐私和数据安全问题对于这些数字健康解决方案的广泛采用至关重要.
更多相关视频
08:27Dynamic Adhesion Assay for the Functional Analysis of Anti-adhesion Therapies in Inflammatory Bowel Disease
Published on: September 20, 2018
7.4K
15:49Flexible Colonoscopy in Mice to Evaluate the Severity of Colitis and Colorectal Tumors Using a Validated Endoscopic Scoring System
Published on: October 16, 2013
31.7K
相关概念视频
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
295
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
295
01:29Inflammatory Bowel Disease IV: Pharmacological Management
89
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
89
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
114
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
114
01:30Inflammatory Bowel Disease II: Crohn's Disease
158
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
158
01:17Chronic Bowel Disorders: Introduction
378
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
378
01:21Inflammatory Bowel Disease V: Surgical Management
87
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
87